SQZ Biotechnologies Co
SQZDelisted Jul 19, 2023- Industry
- Biological Products, (No Diagnostic Substances)
- SEC CIK
- 0001604477
SQZ Biotechnologies Co was delisted on Jul 19, 2023; its insiders filed their last Form 4 on Jun 15, 2023; 31 institutions reported holding it in 13F filings for Q2 2023, worth $2.96M in total; Maverick Capital was the only superinvestor holding it.
Q4 2022 vs. Q3 2022
How the institutions holding SQZ Biotechnologies Co changed between Q3 2022 and Q4 2022.
All holders in Q4 2022All holders in Q3 2022
| Measure | Q3 2022 | Of which not filed for Q4 2022 | Q4 2022 | Change |
|---|---|---|---|---|
| Holders | 48 | 2 | 36 | −10 |
| Shares | 14.7M | 1.46M | 12.7M | −563.0K (−4.3%) |
| Value | $33.5M | $3.33M | $9.36M | −$20.8M (−68.9%) |
2 institutions that held it in Q3 2022 haven't filed for Q4 2022 yet. Not filing isn't selling, so the changes leave them out.
New holders (3)
Institutions that held SQZ Biotechnologies Co at the end of Q4 2022 but not at the end of Q3 2022.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| Jane Street Group, LLC | 42,919 | $31.8K | 0.00% |
| Advisors Management Group Inc | 14,000 | $10.0K | 0.00% |
| HRT Financial LP | 12,987 | $9.00K | 0.00% |
Sold out (13)
Institutions that held SQZ Biotechnologies Co at the end of Q3 2022 and filed for Q4 2022 without it.
| Institution | Shares, Q3 2022 | Value, Q3 2022 |
|---|---|---|
| Dakota Wealth Management | 20,000 | $46.0K |
| Qube Research & Technologies Ltd | 17,679 | $40.0K |
| Citadel Advisors LLC | 16,891 | $38.0K |
| Two Sigma Investments, LP | 13,620 | $31.0K |
| Balyasny Asset Management LLC | 12,404 | $28.0K |
| ETF Managers Group, LLC | 8,631 | $20.0K |
| BNP Paribas Arbitrage, SA | 4,247 | $9.68K |
| UBS Group AG | 3,337 | $8.00K |
| JPMorgan Chase & Co | 2,075 | $5.00K |
| TD Waterhouse Canada Inc. | 1,000 | $3.15K |
| Group One Trading, L.P. | 100 | $0 |
| Simplex Trading, LLC | 403 | $0 |
| Hudock, Inc. | 350 | $0 |
Not filed for Q4 2022 yet (2)
Institutions that held SQZ Biotechnologies Co at the end of Q3 2022 and haven't filed a 13F for Q4 2022. Not filing isn't selling, so they aren't counted as sold out.
| Institution | Shares, Q3 2022 | Value, Q3 2022 |
|---|---|---|
| NanoDimension, Inc. | 1,445,221 | $3.29M |
| ACT Capital Management, LLC | 16,000 | $36.0K |